Area of research
Pathology and Forensic Medicine · Neurology
Research interest
Research focused on Multiple sclerosis and Complement system, with related work in Rituximab, Thematic analysis, CD8. Notable publications include 'Complement activation in multiple sclerosis plaques: an immunohistochemical analysis', 'Complement is activated in progressive multiple sclerosis cortical grey matter lesions', and 'Rituximab in neurological disease: principles, evidence and practice'.
A disease-specific convergence of host and Epstein–Barr virus genetics in multiple sclerosis
Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trial
Sterol imbalances and cholesterol‐24‐hydroxylase dysregulation is linked to the underlying progression of multiple sclerosis
Real‐world persistence of multiple sclerosis disease‐modifying therapies
Algorithmic approach to finding people with multiple sclerosis using routine healthcare data in Wales
Algorithmic Identification of Multiple Sclerosis in the SAIL databank
Do Early Relapses Predict the Risk of Long‐Term Relapsing Disease in an Adult and Paediatric Cohort with <scp>MOGAD</scp>?
CCN3 is dynamically regulated by treatment and disease state in multiple sclerosis
2019 European Thyroid Association Guidelines on the Management of Thyroid Dysfunction following Immune Reconstitution Therapy
Rituximab in neurological disease: principles, evidence and practice
Measurement of soluble CD59 in CSF in demyelinating disease: Evidence for an intrathecal source of soluble CD59
New treatments in Alzheimer’s disease
Tissue microarray methodology identifies complement pathway activation and dysregulation in progressive multiple sclerosis
Cannabidiol as a treatment for epilepsy
Complement is activated in progressive multiple sclerosis cortical grey matter lesions
Targeted suppression of autoreactive CD8+ T-cell activation using blocking anti-CD8 antibodies
Stem cell treatment for multiple sclerosis
‘You are just left to get on with it’: qualitative study of patient and carer experiences of the transition to secondary progressive multiple sclerosis
Complement activation in multiple sclerosis plaques: an immunohistochemical analysis
COMPLEMENT ACTIVATION IN MS: AN IMMUNOHISTOCHEMICAL ANALYSIS
A role for the complement alternative pathway in the pathology of multiple sclerosis grey matter lesions
A neurological presentation of intravascular B-cell lymphoma
176 Intravascular B cell lymphoma: a case series